• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Diabetes News in the New Year


The initial research findings of 2016 include a link between early elevated BMI and later diabetes and heightened dementia risk in women.

© Bochkarev Photography/Shutterstock.com

© Bochkarev Photography/Shutterstock.com

Early elevated BMI is associated with later diabetes, dementia risk is increased in women with diabetes, lung capacity is decreased with diabetes and metabolic syndrome-these are some of the key diabetes research findings of early 2016.

Catch up here on the latest diabetes headlines.


Please click to go to the next page.

Early Elevated BMI Tied to Later Diabetes

Higher body mass index (BMI) at age 21 years is associated with later diabetes incidence. Higher BMI is not linked with myocardial infarction (MI) or stroke.

Higher BMI in middle age is strongly associated with all outcomes.

Early obesity prevention may reduce later type 2 diabetes risk, more than MI and stroke.


Please click to go to the next page.

Greater Dementia Risk in Women With Diabetes

The risk of dementia is about 60% greater in persons who have type 2 diabetes than in those who do not.

The additional risk is greater in women with vascular dementia but not in those with nonvascular dementia.


Please click to go to the next page.

Lower Lung Capacity With Diabetes and Metabolic Syndrome

Researchers investigated the dose-response relationship between pulmonary function measurements (eg, forced expiratory volume in one second [FEV1]) and risk of metabolic syndrome or type 2 diabetes.

Lower lung capacity measurements were more prevalent in adults with 1 of the conditions. Disease risk was lowest with an FEV1 of 2.65 L to 2.76 L.

The findings suggest screening for type 2 diabetes and metabolic syndrome in patients with obstructive lung disease and to ensure there was no abnormal glucose metabolism before the start of steroids.


Please click to go to the next page.

Prevent Gestational Diabetes Mellitus With Lifestyle Intervention

The incidence of gestational diabetes mellitus in high-risk pregnant women was reduced by 39% with a moderate individualized lifestyle intervention.

Each woman in the intervention group received counseling on diet, physical activity, and weight control from trained study nurses and had a group meeting with a dietitian.

Women in the intervention group increased their leisure time physical activity and improved their dietary quality more than women in the control group.

The findings may have major health consequences for mothers and their children.


Please click to go to the next page.

Peripheral Insulin Resistance Predicts Liver Damage in Nondiabetic Patients

The oral glucose insulin sensitivity (OGIS) index is associated with peripheral insulin sensitivity in nonalcoholic fatty liver disease (NAFLD).

The index is inversely associated with an increased risk of significant and advanced liver damage in nondiabetic patients with NAFLD.

Both OGIS and NAFLD fibrosis score identified advanced (F3/F4) fibrosis, but OGIS predicted it better than NAFLD fibrosis score and was able to discriminate F2 from F3/F4.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2024 MJH Life Sciences

All rights reserved.